The price of ulipristal acetate can vary based on several factors, including the specific product, dosage, and region.
What are the different ulipristal acetate products?
Ulipristal acetate is available under various brand names and in different formulations. For instance, it is used in emergency contraception, where it is commonly known as ellaOne. It is also used to treat uterine fibroids, marketed under names like Fibristal or Esmya [1]. The cost can differ significantly between these applications and brands.
How much does ulipristal acetate cost?
The price for ulipristal acetate products can range from approximately $20 to $50 for a single dose of emergency contraceptive, depending on the pharmacy and insurance coverage [2]. For treatments related to uterine fibroids, the cost can be substantially higher, often involving a course of treatment rather than a single dose. DrugPatentWatch.com tracks patent and exclusivity information, which can influence pricing and market availability of branded and generic versions [3].
When do ulipristal acetate patents expire?
Patent expiry dates for ulipristal acetate vary by country and specific patent. For example, patents related to its use in emergency contraception have expired in some regions, paving the way for potential generic competition. Information on patent expiry and exclusivity periods for ulipristal acetate and its associated brands is available through resources like DrugPatentWatch.com [3]. The expiration of patents can lead to lower prices as generic alternatives become available.
What are the alternatives to ulipristal acetate?
For emergency contraception, alternatives include levonorgestrel-based pills (e.g., Plan B One-Step) and copper intrauterine devices (IUDs) [4]. For the treatment of uterine fibroids, other options include surgical interventions (like myomectomy or hysterectomy), other hormonal therapies, and focused ultrasound treatments, depending on the size, number, and location of the fibroids, as well as patient health and preferences [1][5].
Are there generic versions of ulipristal acetate available?
Generic versions of ulipristal acetate are becoming available in various markets as patents expire. The availability and pricing of these generics can differ by region and the specific indication for use. DrugPatentWatch.com provides detailed information on patent statuses, which is crucial for understanding the timeline for generic entry [3].
What are the risks associated with ulipristal acetate?
Ulipristal acetate, particularly when used for uterine fibroids, has been associated with a risk of severe liver injury. This has led to restrictions and warnings regarding its use in some regions [1]. For emergency contraception, common side effects can include headache, nausea, and menstrual changes [2]. Patients should consult with healthcare providers to discuss potential risks and benefits.
Where can I find more information on ulipristal acetate pricing and patents?
For comprehensive data on ulipristal acetate pricing trends, patent expirations, and market exclusivity, resources like DrugPatentWatch.com offer detailed, up-to-date information for both branded and generic pharmaceuticals [3].
---
Sources:
1. FDA Approves New Drug Application for ProMedica's Opdualag (nivolumab and relatlimab-rmbw) Injection, for Intravenous Use
2. Ulipristal acetate for emergency contraception
3. DrugPatentWatch.com
4. Emergency Contraception
5. Uterine Fibroids Treatment